Y-C Tsai
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Immunotherapy and Immune Responses
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Wei‐Yu Chen (4 shared papers)JuanJuan Yin (3 shared papers)Michelle K.Y. Siu (3 shared papers)Chien‐Fu Hung (2 shared papers)T.‐C. Wu (2 shared papers)Lan He (1 shared paper)Chun‐Liang Chen (2 shared papers)Hy Levitsky (1 shared paper)
- Journals
- Gene Therapy (2 papers)Oncogene (2 papers)Nanotechnology (2 papers)Molecular Cancer Therapeutics (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- TaiwanUnited StatesGermany
In The Last Decade
Y-C Tsai
23 papers receiving 400 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 103
- Immunology 72
- Biotechnology 29
- Molecular Biology 168
- Radiology, Nuclear Medicine and Imaging 56
Countries citing papers authored by Y-C Tsai
This map shows the geographic impact of Y-C Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y-C Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y-C Tsai more than expected).
Fields of papers citing papers by Y-C Tsai
This network shows the impact of papers produced by Y-C Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y-C Tsai. The network helps show where Y-C Tsai may publish in the future.
Co-authors
The 25 scholars most cited alongside Y-C Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 75 | |
| 2 | 2007 | 45 | |
| 3 | 2006 | 44 | |
| 4 | 2007 | 42 | |
| 5 | 2017 | 33 | |
| 6 | 2017 | 26 | |
| 7 | 2016 | 23 | |
| 8 | 2004 | 20 | |
| 9 | 2008 | 16 | |
| 10 | Molecular analysis of human bladder cancer. | 1990 | 16 |
| 11 | 2009 | 13 | |
| 12 | Sialyltransferase family members and cervix squamous cell carcinoma. | 2002 | 12 |
| 13 | 2020 | 10 | |
| 14 | 2012 | 9 | |
| 15 | Multivariate analyses of the relationship between umbilical cord length and obstetric outcome. | 1996 | 8 |
| 16 | 2013 | 4 | |
| 17 | NitroG-L-arginine methyl ester decreases minimum alveolar concentration of isoflurane and reduces brain nitric oxide synthase activity in rats. | 1998 | 4 |
| 18 | 2017 | 2 | |
| 19 | Surgical management of musculoskeletal involvement in hemophilic patients. | 1989 | 2 |
| 20 | ISG15 as a biomarker for tumor cell sensitivity/resistance to topoisomerase I-targeting drugs. | 2008 | 1 |
About Y-C Tsai
Y-C Tsai is a scholar working on Molecular Biology, Immunology, Oncology, Genetics and Biomedical Engineering, having authored 23 papers that have together received 408 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Virus-based gene therapy research (2 papers), Prostate Cancer Treatment and Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Near-Field Optical Microscopy (2 papers), Cytokine Signaling Pathways and Interactions (1 paper), Environmental Toxicology and Ecotoxicology (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (103 citations), Immunology (72 citations), Biotechnology (29 citations), Molecular Biology (168 citations) and Radiology, Nuclear Medicine and Imaging (56 citations). Y-C Tsai has collaborated with scholars based in Taiwan, United States and Germany. Frequent co-authors include Wei‐Yu Chen, JuanJuan Yin, Michelle K.Y. Siu, Chien‐Fu Hung, T.‐C. Wu, Lan He, Chun‐Liang Chen, Hy Levitsky, George Coukos and Lan He. Their work appears in journals such as Gene Therapy, Oncogene, Nanotechnology, Molecular Cancer Therapeutics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.